tumoral biopsy

PROCEDURE2 trials

Sponsors

Gustave Roussy, Cancer Campus, Grand Paris, Assistance Publique - Hôpitaux de Paris

Conditions

MelanomaMetastatic Solid Tumors (Any Localization)

Unknown Phase

Molecular Screening for Cancer Treatment Optimization

Gustave Roussy, Cancer Campus, Grand ParisMetastatic Solid Tumors (Any Localization)

Start: 2011-10-28End: 2020-10-31Target: 2150Updated: 2020-02-17

Immune Profiles Evolution Under Immunotherapy for Melanoma

RecruitingNCT04576429

Assistance Publique - Hôpitaux de ParisMelanoma

Start: 2021-01-27End: 2031-01-31Target: 360Updated: 2025-04-06

Related Papers

Assessing actionability and incidental findings of germline variants in two precision oncology trials.

2024-08-031 citations

Abstract 3458: Resistance to selective FGFR inhibitors in <i>FGFR</i>-driven urothelial cancer

Cancer Research2023-04-04

ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling – a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial

BMC Cancer2023-02-2223 citations

Epigenetic gene alterations in metastatic solid tumours: results from the prospective precision medicine MOSCATO and MATCH-R trials.

2022-07-211 citations

Abstract 2953: Overall survival results of the single-institution molecular screening MOSCATO trial in hard-to-treat advanced cancers

Cancer Research2018-07-01

Feasibility and benefit of molecularly-informed enrollment into early phase trials for patients with recurrent gliomas.

Journal of Clinical Oncology2018-05-20

Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients

PLoS ONE2017-11-2199 citations

Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial.

2017-11-14119 citations

MET aberrations across multiple tumor types: Results of a molecular screening program (MOSCATO 01).

Journal of Clinical Oncology2017-05-20

Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial.

2016-01-1293 citations

Abstract 2401: Circulating cell-free tumor DNA (cfDNA) analysis of 50-genes by next-generation sequencing (NGS) in the prospective MOSCATO trial

Cancer Research2015-08-013 citations

Molecular screening for cancer treatment optimization (MOSCATO 01) in pediatric patients: First feasibility results of a prospective molecular stratification trial.

Journal of Clinical Oncology2014-05-2010 citations